There May Be Reason For Hope In China Resources Boya Bio-pharmaceutical GroupLtd's (SZSE:300294) Disappointing Earnings

Simply Wall StOct 25 18:28 ET

Liberal Arts Biotech: Report for the third quarter of 2024

SZSIOct 24 12:00 ET · Announcements

Chinare Pharma (03320): China Resources Boya Bio-pharmaceutical Group's net income in the first three quarters was approximately 0.412 billion yuan, a decrease of 13.01% year-on-year.

china resources pharma (03320) announced the performance of china resources boya bio-pharmaceutical group for the first 9 months of 2024, with total operating income of approximately 12.4...

Zhitong FinanceOct 24 07:01 ET

Shareholders in China Resources Boya Bio-pharmaceutical GroupLtd (SZSE:300294) Are in the Red If They Invested Three Years Ago

Simply Wall StAug 29 21:09 ET

CR Boya's H1 Attributable Profit Falls 3% as Revenue Plunges 42%

MT NewswiresAug 26 03:26 ET

China Resources Boya Bio-pharmaceutical Group: Summary of Half-Year Report in 2024.

SZSIAug 23 12:00 ET · Announcements